308 related articles for article (PubMed ID: 27222115)
1. Leptin directly promotes T-cell glycolytic metabolism to drive effector T-cell differentiation in a mouse model of autoimmunity.
Gerriets VA; Danzaki K; Kishton RJ; Eisner W; Nichols AG; Saucillo DC; Shinohara ML; MacIver NJ
Eur J Immunol; 2016 Aug; 46(8):1970-83. PubMed ID: 27222115
[TBL] [Abstract][Full Text] [Related]
2. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.
Gerriets VA; Kishton RJ; Nichols AG; Macintyre AN; Inoue M; Ilkayeva O; Winter PS; Liu X; Priyadharshini B; Slawinska ME; Haeberli L; Huck C; Turka LA; Wood KC; Hale LP; Smith PA; Schneider MA; MacIver NJ; Locasale JW; Newgard CB; Shinohara ML; Rathmell JC
J Clin Invest; 2015 Jan; 125(1):194-207. PubMed ID: 25437876
[TBL] [Abstract][Full Text] [Related]
3. Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.
Sun Y; Tian T; Gao J; Liu X; Hou H; Cao R; Li B; Quan M; Guo L
J Neuroimmunol; 2016 Mar; 292():58-67. PubMed ID: 26943960
[TBL] [Abstract][Full Text] [Related]
4. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
[TBL] [Abstract][Full Text] [Related]
5. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276
[TBL] [Abstract][Full Text] [Related]
6. Intranuclear Delivery of HIF-1α-TMD Alleviates EAE
Shin JS; Kim I; Moon JS; Ho CC; Choi MS; Ghosh S; Lee SK
Front Immunol; 2021; 12():741938. PubMed ID: 34745114
[TBL] [Abstract][Full Text] [Related]
7. A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance.
Aqel SI; Yang X; Kraus EE; Song J; Farinas MF; Zhao EY; Pei W; Lovett-Racke AE; Racke MK; Li C; Yang Y
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33411696
[TBL] [Abstract][Full Text] [Related]
8. Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes T
Aqel SI; Kraus EE; Jena N; Kumari V; Granitto MC; Mao L; Farinas MF; Zhao EY; Perottino G; Pei W; Lovett-Racke AE; Racke MK; Fuchs JR; Li C; Yang Y
Clin Exp Immunol; 2019 May; 196(2):215-225. PubMed ID: 30615197
[TBL] [Abstract][Full Text] [Related]
9. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells.
Shi LZ; Wang R; Huang G; Vogel P; Neale G; Green DR; Chi H
J Exp Med; 2011 Jul; 208(7):1367-76. PubMed ID: 21708926
[TBL] [Abstract][Full Text] [Related]
10. TNFR2 on non-haematopoietic cells is required for Foxp3+ Treg-cell function and disease suppression in EAE.
Tsakiri N; Papadopoulos D; Denis MC; Mitsikostas DD; Kollias G
Eur J Immunol; 2012 Feb; 42(2):403-12. PubMed ID: 22105853
[TBL] [Abstract][Full Text] [Related]
11. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.
Michalek RD; Gerriets VA; Jacobs SR; Macintyre AN; MacIver NJ; Mason EF; Sullivan SA; Nichols AG; Rathmell JC
J Immunol; 2011 Mar; 186(6):3299-303. PubMed ID: 21317389
[TBL] [Abstract][Full Text] [Related]
13. Polyclonal Treg cells modulate T effector cell trafficking.
Davidson TS; Shevach EM
Eur J Immunol; 2011 Oct; 41(10):2862-70. PubMed ID: 21728170
[TBL] [Abstract][Full Text] [Related]
14. microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance.
Fujiwara M; Raheja R; Garo LP; Ajay AK; Kadowaki-Saga R; Karandikar SH; Gabriely G; Krishnan R; Beynon V; Paul A; Patel A; Saxena S; Hu D; Healy BC; Chitnis T; Gandhi R; Weiner HL; Murugaiyan G
J Clin Invest; 2022 May; 132(10):. PubMed ID: 35298438
[TBL] [Abstract][Full Text] [Related]
15. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
16. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
17. Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis.
Wang J; Lu ZH; Gabius HJ; Rohowsky-Kochan C; Ledeen RW; Wu G
J Immunol; 2009 Apr; 182(7):4036-45. PubMed ID: 19299701
[TBL] [Abstract][Full Text] [Related]
18. Metformin attenuates bleomycin-induced scleroderma by regulating the balance of Treg/Teff cells and reducing spleen germinal center formation.
Wang Y; Zhang S; Liang Z; Feng M; Zhao X; Qin K; Gao C; Li X; Guo H; Luo J
Mol Immunol; 2019 Oct; 114():72-80. PubMed ID: 31344551
[TBL] [Abstract][Full Text] [Related]
19. GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice.
Orsini H; Araujo LP; Maricato JT; Guereschi MG; Mariano M; Castilho BA; Basso AS
Brain Behav Immun; 2014 Mar; 37():177-86. PubMed ID: 24362236
[TBL] [Abstract][Full Text] [Related]
20. 4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cells.
Kim YH; Choi BK; Shin SM; Kim CH; Oh HS; Park SH; Lee DG; Lee MJ; Kim KH; Vinay DS; Kwon BS
J Immunol; 2011 Aug; 187(3):1120-8. PubMed ID: 21715692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
